Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

322 results about "Drug coating" patented technology

Balloon catheter and methods of using the same

PendingUS20250352774A1Balloon catheterEustachian tube disordersAirway wall
Methods of treating a central airway obstruction (CAO), benign airway stenosis, asthma, chronic obstructive pulmonary disease (COPD), or an airway tumor in a human subject, methods of treating chronic rhinosinusitis (CRS) or chronic rhinosinusitis with nasal polyps (CRSwNP) in a human subject, methods of treating a eustachian tube disorder in a human subject, and devices and systems for performing the methods. A method of treating a central airway obstruction (CAO), benign airway stenosis, asthma, chronic obstructive pulmonary disease (COPD), or an airway tumor in a human subject includes inserting a drug-coated balloon catheter into a target site in a trachea, mainstem bronchus, bronchus intermedius, lobar bronchus, segmental bronchus, or sub-segmental bronchus, wherein the balloon is coated with a coating layer including the therapeutic agent and one or more additives. The therapeutic agent includes paclitaxel, sirolimus, or a derivative thereof. The method includes inflating the balloon to dilate the airway and deliver a therapeutic agent to the airway wall. The method includes deflating the balloon. The method also includes withdrawing the balloon catheter from the target site.
Owner:AIRIVER MEDICAL INC

Prostate stent and stent conveying device

The invention discloses a prostate stent and a stent conveying device, and the prostate stent comprises a stent body which comprises a plurality of stent wires; the diaphragm comprises a diaphragm sleeve and a diaphragm piece, the diaphragm sleeve is arranged on the support wire in a sleeving mode, the diaphragm piece is an elastic sheet, the diaphragm piece is in a bent wave-shaped loose state, and when the support wire is formed by twisting a plurality of strands of flat wires into a twisted shape, the diaphragm material permeates into twisted grooves and gaps between wire materials on the support wire; and drug coatings are arranged on the outer surfaces of the stent body and the diaphragm. The invention further discloses a stent conveying device. Compared with the prior art, the problem that an existing traditional prostate stent is difficult to take out after an operation is solved.
Owner:SUZHOU SIAN MEDICAL TECH CO LTD

Polymer encapsulated drug particles

Various embodiments disclosed relate to polymer encapsulated drug particles and drug release coatings comprising the polymer encapsulated drug particles, as well as drug coated balloon catheters for treating, preventing, or reducing recurrence of body lumen stenosis and methods of use thereof. A drug coated balloon catheter for delivering a therapeutic agent to a body lumen stenosis target site includes an elongated balloon. The balloon catheter includes a coating layer covering the outer surface of the balloon. The coating layer comprises: polymer encapsulated drug particles; or a drug release coating comprising polymer encapsulated drug particles; or a therapeutic agent and a first and / or second additive; or a combination thereof.
Owner:TONIC MEDICAL INC

Polymer-encapsulated drug particles

Various embodiments disclosed relate to polymer-encapsulated drug particles and a drug-releasing coating including the same, as well as drug-coated balloon catheters for treating, preventing, or reducing the recurrence of strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes the polymer-encapsulated drug particles; or a drug-releasing coating including the polymer-encapsulated drug particles; or a therapeutic agent and a first and / or second additive; or a combination thereof.
Owner:TONIC MEDICAL INC

Preparation method of dual-pH intelligent response drug-loaded ureteral stent

The invention discloses a preparation method of a dual-pH intelligent response drug-loaded ureteral stent, which belongs to the technical field of medical instruments, and is characterized in that the dual-pH intelligent response drug-loaded ureteral stent comprises a dual-pH intelligent response drug-loaded coating and a bare stent; wherein the dual pH intelligent response drug-loading coating contains polymer-modified porous silicon dioxide drug-loading particles, and the main effect of the drug-loading coating is that after the pH of the internal environment of the ureteral stent is changed due to bacterial infection, the antibacterial agent is controllably released through the structural change of the drug-loading particles or the property of the surface polymer is changed, so that the bactericidal ability is improved; and a complex infection environment can be accurately dealt with.
Owner:SHANDONG RIENTECH MEDICAL TECH

Drug Coatings for Medical Devices

The present disclosure concerns drug coating layers for medical devices that cover an exterior surface or portion thereof. The drug coating layers include a bioabsorbable material with a therapeutic or a polymer microparticle loaded with a therapeutic embedded therein. As the material is bioabsorbed the therapeutic is released and available to provide localized activity in a subject. In some aspects, the drug coating layer is of a material that due to the body temperature of the subject becomes tacky and allows for adhesion to the vessel wall.
Owner:BARD PERIPHERAL VASCULAR INC

Drug eluting stent

The invention discloses a drug eluting stent, which comprises a stent main body and a plurality of thorn-shaped components, the stent main body has a radially compressible contraction state and a radially self-expanding expansion state to support blood vessels, and the plurality of thorn-shaped components are arranged on the outer surface of the stent main body and coated with a drug coating for inhibiting vascular restenosis. The spine-shaped components are arranged on the stent body and are configured to protrude towards the outer side of the stent body from the outer surface of the stent body to penetrate into calcified lesions on the inner wall of a blood vessel when the stent body is switched from the contraction state to the expansion state, each spine-shaped component is provided with a part capable of generating elastic deformation, and the spine-shaped components are configured to be capable of generating deformation in a self-adaptive mode according to the thickness of the contacted calcified lesions. Therefore, the medicine can be uniformly distributed in a target lesion area, and the utilization rate of the medicine and the treatment effect are remarkably improved.
Owner:HANGZHOU EXCEED MEDICAL TECH CO LTD

Drug structural coating having super-hydrophobic property and preparation method therefor

PCT designated stage expiredWO2025011542A1Powder deliverySurgeryReactive oxygen radicalsPolyphenol
The present application belongs to the technical field of biomedical functional materials, and particularly relates to a drug structural coating having a super-hydrophobic property and a preparation method therefor. The preparation method in the present application uses a phenol amine compound to undergo oxidation, crosslinking and polymerization reactions under the action of an oxidant to generate a polyphenol nanoparticle film layer outside drug-loaded nanoparticles. The polyphenol nano film layer not only serves as a "protective layer" for the drug-loaded nanoparticles and a cross-linking substance between the drug-loaded nanoparticles, but also can immobilize the drug-loaded nanoparticles onto the surface of a substrate material, so that after reaction and deposition, a drug nanometer multi-level structural coating having a micro-nano topological structure can be formed on the surface of the substrate material. During an irradiation process, an ultraviolet cross-linking device can generate a large number of active oxygen free radicals, so that by means of ultraviolet irradiation on a sample, the active oxygen free radicals fully react with a micelle protective layer in the drug coating, so as to convert hydrophilic phenolic hydroxyl in the phenol amine into hydrophobic quinonyl. Therefore, the micro-nano topological structure and the hydrophobic group cooperatively act to endow the surface of the material with the super-hydrophobic property.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Degradable woven stent with anti-fibrosis drug coating for treating urethrostenosis

The invention discloses an anti-fibrosis drug coating degradable woven stent for treating urethrostenosis, the stent is a hollow cylinder formed by spirally weaving wires, the wires are made of biodegradable polymer materials, the surface of the stent is coated with a drug coating, anti-fibrosis drugs are selected as the drugs, and the anti-fibrosis drug coating is made of biodegradable polymer materials. The drug coating is prepared by using an ultrasonic atomization spraying method; the biodegradable polymer material comprises one or a compound of more than one of poly L-lactic acid, poly D, L-lactic acid, poly (L-lactic acid / D, L-lactic acid), poly (glycolide / lactide), poly (glycolide-lactide), poly (L-lactic acid / caprolactone), poly (glycolide / caprolactone), poly (D, L-lactic acid / caprolactone), polydioxanone and the like. The stent body is made into a self-expanding stent by adopting a weaving method; the biodegradable ureteral stent with the drug coating has good biocompatibility, degradability and mechanical property, and has a wide market application prospect.
Owner:SOUTHEAST UNIV

Drug delivery beyond the blood-brain barrier using shock waves

Described herein are shock wave catheters and methods of use thereof for delivering an active agent of a drug to the CNS via a body lumen or cavity, such as sinonasal cavity, which can bypass the blood-brain barrier (BBB). The catheters described herein can be advanced through an intranasal passage to the nasal cavity such that at least a portion of the enclosure is disposed in the nasal cavity. The enclosure can be coated with a drug coating. The method can include filling the enclosure with a conductive fluid. At least one shock wave can be generated at a shock wave emitter of the catheter disposed within the enclosure. The at least one shock wave can cause a therapeutically effective amount of the active agent of the drug coating to be delivered to the CNS via tissue of the nasal cavity, in turn, treating central nervous system diseases.
Owner:SHOCKWAVE MEDICAL INC

Drug coating balloon catheter and preparation method thereof

The invention belongs to the technical field of medical instruments. The invention discloses a drug coating balloon catheter and a preparation method thereof. In one aspect, a drug coated balloon catheter includes a catheter with a balloon; a drug coating at least comprising an inner coating and an outer coating is arranged on the outer wall of the balloon, and the inner coating and the outer coating are provided with drug active ingredients and different carriers respectively; when the balloon is expanded, the inner coating and the outer coating are separated from the balloon through the state change of the temperature-sensitive carrier of the inner coating under the body temperature environment of a patient and the hydration effect, and the outer coating is used for promoting corresponding active pharmaceutical ingredients to be transferred into target tissues through the carrier of the outer coating when the outer coating is separated from the balloon. On the other hand, the invention provides a preparation method of the drug coating balloon catheter. The preparation method has the advantages that the adhesiveness of the drug coating on the balloon can be effectively improved so as to reduce the delivery loss, and the release rate of the drug coating on diseased tissues can be improved so as to improve the drug transfer capacity.
Owner:GUANGZHOU WELLLEAD MEDICAL EQUIP CO LTD

A processing method for medical titanium alloy coronary artery drug-coated stent

The present invention belongs to the field of cardiovascular stent processing technology, and relates to a processing method for a medical titanium alloy coronary artery drug-coated stent. The chemical composition and mass percentage of the titanium alloy are: Mn 5.0% to 14.0%, Fe≤0.30%, O≤0.16%, N≤0.01%, H≤0.001%, and the remainder is Ti. The present invention adopts a vacuum consumable arc furnace to melt the alloy ingot, and after forging and hot rolling, a titanium alloy rod is obtained, and then mechanical perforation, peeling, centerless grinding, cold rolling, cold drawing and straightening are performed to obtain a finished titanium alloy capillary, and a metal stent is prepared by microsecond fiber laser engraving, vacuum heat treatment and electrochemical polishing. Subsequently, a drug solution is sprayed on the outer surface of the metal stent using a sprayer, and dried in a clean environment, thereby preparing a titanium alloy coronary artery drug-coated stent.
Owner:GENERAL HOSPITAL OF THE NORTHERN WAR ZONE OF THE CHINESE PEOPLES LIBERATION ARMY +2

Drug eluting covered stent

Covered stents may be coated with or otherwise include a drug eluting composition. An illustrative stent may comprise an elongated tubular body having a strut framework defining a plurality of open cells. A polymeric coating may be disposed on a surface of the elongated tubular body and extending across the plurality of open cells and a first drug coating composition disposed on a surface of the polymeric coating.
Owner:BOSTON SCIENTIFIC SCIMED INC

Drug-coated balloon catheters for body lumens

PendingJP2025011111AOrganic active ingredientsBalloon catheterVascular bodyCancer relapse
To provide drug-coated balloon catheters for treating, preventing or reducing the recurrence of a stricture and / or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen, and methods of using the same.SOLUTION: A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism, which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.SELECTED DRAWING: Figure 5A
Owner:UROTRONIC

Drug eluting stent

The invention discloses a drug eluting stent, which comprises a stent main body and a plurality of thorn-shaped components, the stent main body has a radially compressible contraction state and a radially self-expanding expansion state to support blood vessels, and the plurality of thorn-shaped components are arranged on the outer surface of the stent main body and coated with a drug coating for inhibiting vascular restenosis. The spine-shaped components protrude from the outer surface of the stent body to the outer side of the stent body so as to penetrate into calcification lesions on the inner wall of a blood vessel when the stent body is switched from the contraction state to the expansion state, each spine-shaped component comprises a spine section, and the spine section at least comprises a first section and a second section of which the roots are connected together. The first section and the second section are attached to each other in a natural state to form a compact structure, and can elastically deform and be separated relative to the root part when subjected to opposite acting force from calcification lesion, so that the calcification lesion can be punctured at a larger angle, the slippage risk is reduced, the puncturing efficiency is improved, and the puncturing effect is improved. Therefore, the effect of inhibiting vascular restenosis is enhanced.
Owner:HANGZHOU EXCEED MEDICAL TECH CO LTD

An integrated device for inspection, medication and sampling

The present invention relates to the technical field of medical devices, and discloses an integrated device for inspection, medication and sampling, comprising a handle, the top of the handle is fixedly connected to a shell, the bottom of the inner wall of the shell is fixedly connected to an inner tube, a top cover is installed on the top of the shell, a sampling cotton swab is plugged into the top of the top cover, a plurality of leakage holes are opened on the surface of the shell, the inner diameter of the shell is fixedly connected to a partition, and the bottom of the shell is rotatably connected to a matching plate. The integrated device for inspection, medication and sampling, by providing a medicine coating component, allows the medicine to be evenly applied to the surface of the shell, and then by placing the shell in the vagina, the medicine coated on the surface of the shell is evenly in contact with the inner wall of the vagina, thereby ensuring the uniformity of the medicine coating, improving the medication effect of the device, and being more conducive to the absorption and healing of the vagina by the medicine, and the shell and the inner tube are placed in the vagina, and sampling is performed by contacting the sampling cotton swab with the vagina, so that the medicine application and sampling are completed at the same time, thereby preventing secondary operation and friction damage to the patient's vagina.
Owner:CHONGQING WEIDITE PHARM CO LTD

Drug coating balloon with multi-layer structure and preparation method thereof

The invention relates to the technical field of medical instruments, and discloses a drug coating balloon with a multi-layer structure and a preparation method thereof.A bottom layer of a drug coating, a drug layer and a protective layer are sequentially manufactured on the balloon from inside to outside, the balloon is in a full state when a bottom layer solution and a drug layer solution are sprayed, then the balloon is folded in a sectioning mode, and the drug coating balloon with the multi-layer structure is obtained. And spraying a protective layer solution. The outer layer is a fat-soluble protective layer, the firmness of the dried coating is high, the coating is hardly dissolved when making contact with body fluid, it is guaranteed that the coating can always cover the surface of the medicine layer in the conveying process, the medicine layer is not directly exposed to the body fluid environment, early release is avoided, and medicine conveying loss is reduced. The bottom layer is slightly soluble in water and is always attached to the surface of the balloon before and after the balloon is expanded, and extra particles are not added; the combination between the bottom layer and the medicine layer is strong before the balloon is expanded, the bottom layer is slightly soluble after the balloon is expanded and the bottom layer is in contact with body fluid, the interface combination with the medicine layer is weakened, the medicine layer falls off and is dissolved, and the treatment effect is fully released.
Owner:威高奋威健康科技发展(上海)有限公司

Temporary vascular scaffold and scoring device

Devices and methods for treating a target site in a body lumen are provided. A medical device includes a stent-like structure including a plurality of scoring and non-scoring filaments interwoven with one another. Generally, the stent-like structure will have more non-scoring filaments than scoring filaments to provide greater structural support and to focus the scoring forces on only a few select areas. The stent-like structure is expanded within the target site to score the target site and to provide temporary structural support while the target site is infused with a therapeutic agent. Such therapeutic agent infusion occurs with the use of a drug eluting or drug coated balloon disposed within the stent-like structure or by occluding the target site and introducing a drug into the occluded target site to sit for a period of time.
Owner:NFINIUM VASCULAR TECHNOLOGIES LLC

Absorbable tracheal stent with drug coating

The invention relates to the technical field of medical instruments, in particular to an absorbable tracheal stent containing a drug coating, which comprises a cylindrical shell, the shell comprises a longitudinal skeleton, a ring-shaped skeleton, an extension drug groove and an assembly groove, and the extension drug groove is filled with a drug coating strip; a covering film is pasted on the outer portion of the shell and comprises a tightening film, a contact film and a sealing film. According to the invention, the sealing film is firstly degraded in the trachea of a patient, and the stress on the shell corresponding to the outward expanding medicine groove is released, so that the outward expanding medicine groove is expanded, the outer diameter of the whole tracheal stent is increased, and the medicine coating strip is driven to synchronously expand outwards to abut against an affected part, so that the stent can be automatically degraded in the body of the patient; and the expansion force of the stent can be slowly released in the degradation process, so that the reduction of the expansion force of the stent caused by thinning of the wall of the degraded stent or natural growth of the trachea is counteracted, the expansion force of the stent is dynamically maintained, and the stability of the stent is improved.
Owner:THE AFFILIATED HOSPITAL OF QINGDAO UNIV

Paclitaxel drug coating balloon dilatation catheter as well as preparation method and application thereof

The invention relates to the technical field of medical instruments, in particular to a paclitaxel drug coating balloon dilatation catheter and a preparation method and application thereof.The paclitaxel drug coating comprises a substrate layer, a middle layer and an outer layer; the substrate layer comprises paclitaxel and a hydrophilic excipient; the middle layer comprises a lipophilic excipient and a temperature response type polymer; and the outer layer comprises a pH sensitive polymer. The substrate layer is combined with the surface of the balloon, so that excellent conveying stability is provided, the medicine is effectively prevented from falling off prematurely in the conveying process of the catheter, and the firmness of the coating is improved; a micropore network structure is formed in the middle layer, the network structure is expanded under the body temperature condition, the porosity is increased, slow release of the medicine is achieved, the absorption amount of the medicine on the blood vessel wall is effectively increased, and the medicine effect time is prolonged; the solubility of the outer layer is improved in a slightly acidic blood vessel wall environment, so that the release of the medicine is further promoted, and the effective release of the medicine on the blood vessel wall is ensured.
Owner:DK MEDICAL TECH CO LTD

Drug-coated balloon catheters for body lumens

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.
Owner:UROTRONIC

Drug-loaded medical device, drug coating and preparation method and application of drug-loaded medical device and drug coating

ActiveCN118987375AHarm reductionReduced puncture resistanceSurgeryCoatingsPolyvinyl alcoholActive agent
The invention discloses a drug-loaded medical device, a drug coating and a preparation method and application of the drug coating. The drug coating comprises the following components: 0.1 wt%-29.9 wt% of a drug, 70 wt%-99 wt% of a carrier substance and 0.01 wt%-5 wt% of a surfactant, the carrier substance comprises gelatin, sodium polyacrylate, polyacrylic acid, polyvinyl alcohol, sodium alginate, povidone, dextran, polycaprolactone, chitosan, polylactic acid, a glycolide-lactide copolymer, polyglycolide, polyethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 8000, stearic acid, mixed fatty glyceride, polyoxyl stearate, hydrogenated palm oil glyceride and carbomer; the component A is at least one of poloxamer, hydroxypropyl methylcellulose, hydroxy propyl cellulose, methyl cellulose, hydroxyethyl cellulose and polyvinylpyrrolidone; and the molecular weight of the carrier substance is 4000 to 600000. The drug coating disclosed by the invention has good effects in the aspects of firmness, falling condition, friction coefficient, stability, drug release and the like.
Owner:TRUE HEALTH (GUANGDONG HENGQIN) MEDICAL TECHNOLOGY CO LTD

Balloon catheter

PendingCN120204591ABalloon catheterMulti-lumen catheterScoring balloonCatheter hub
The balloon catheter comprises a catheter base, a catheter body, a balloon, an indentation wire and an elastic tube, a medicine coating is arranged on the outer surface of the balloon, the near end of the catheter body is fixed in the catheter base, the balloon is arranged on the far end side of the catheter body, the near end of the elastic tube is fixed in the catheter body, and the indentation wire is arranged on the outer surface of the balloon. The far end of the elastic tube spans the balloon and then is fixed to the far end of the catheter, the nick wire can be arranged in the elastic tube, the catheter and the catheter base in a penetrating mode, and the nick wire can move relative to the elastic tube, the catheter and the catheter base. And the balloon is fully expanded to drive the elastic tube and the nick wire to deform. Through the arrangement of the nick wire and the elastic tube, the balloon not only has the excellent blood vessel dilatation performance of a nick balloon, but also has the function of preventing blood vessel restenosis of a medicine balloon. The use of instruments is reduced, the burden of an operation patient is reduced, the operation time is shortened, and the operation safety is improved.
Owner:LIFETECH SCI (SHENZHEN) CO LTD

Protective coverings for drug coated balloons

PCT designated stage expiredWO2024263155A1CatheterCoatingsPharmacy medicinePharmaceutical drug
The present disclosure concerns protective layers covering drug-coated layers on the external surface of a balloon that offer protection to the drug-coating until the balloon is in positions and ready for inflation. In aspects, the protective layer is water-soluble, meaning that the protective layer starts to dissolve within a subject's circulatory system once introduced. The protective layer is of a sufficient thickness or density over the drug-coating to allow for the balloon to be positioned in situ before exposing completely the drug-coating. The protective layer allows for preservation of therapeutic on the balloon surface, thereby increasing the accuracy of site-specific delivery.
Owner:BARD PERIPHERAL VASCULAR INC

ZIF drug-loaded coating on surface of magnesium matrix and preparation method of ZIF drug-loaded coating

According to the magnesium matrix surface ZIF in-drug coating and the preparation method thereof, magnesium or magnesium alloy serves as a matrix, a ZIF (zeolite imidazole framework-like MOF) drug-loaded coating is loaded on the magnesium matrix through a one-step in-situ synthesis method, the magnesium matrix and the drug-loaded coating form chemical bond combination, the adhesive force is high, the magnesium matrix and the drug-loaded coating are combined more tightly, and the magnesium matrix surface ZIF in-drug coating can be used for preparing the magnesium matrix surface ZIF in-drug coating. And the bonding strength between the coating and the matrix is enhanced. The preparation method is simple, in-situ growth of the ZIF coating on the surface of the magnesium alloy is achieved, introduction of external impurities can be avoided through in-situ synthesis of the ZIF coating, the ZIF coating high in purity is prepared, the biocompatibility and corrosion resistance of the magnesium alloy are remarkably improved, and the coating is endowed with the antibacterial property and the drug release control function.
Owner:ZHENGZHOU UNIV

Self-expanding drug-coated vascular stent

The present invention relates to the technical field of medical devices, and specifically to a self-expanding drug-coated vascular stent, which is a mesh tube structure formed by connecting a plurality of main ribs and a plurality of connecting ribs, wherein the plurality of main ribs are evenly distributed along the circumference, and two adjacent main ribs are connected by connecting ribs; when the mesh tube structure is in an expanded state, the main ribs extend in a sinusoidal waveform, the connecting ribs extend in the same direction as the main ribs, the connecting ribs are connected to the side of the main ribs where the crest or trough is protruding, one side of the same connecting rib is connected to the crest of a main rib, and the other side of the connecting rib is connected to the trough of another adjacent main rib; when the mesh tube structure is in an unfolded and flattened state, the plurality of main ribs are parallel to each other, and the connecting ribs extend in a fishbone shape along the extension direction of the main ribs. Different branch ribs of the connecting ribs exert force on the main ribs, so that the axial flexibility of the vascular stent is better, and the instantaneous non-uniform expansion phenomenon of the vascular stent during the expansion process can be effectively alleviated, and the wall adhesion of the stent after implantation can be ensured.
Owner:SINOMED NEUROVITA TECH INC

Multifunctional anti-stenosis drug coating stent as well as preparation method and application thereof

ActiveCN120459385ASurgeryCoatingsBile duct stricturesPharmaceutical drug
The invention discloses a multifunctional anti-stenosis drug-coated stent which comprises a nickel-titanium stent, the outer surface of the nickel-titanium stent is coated with a PLLA-TPU-based drug-loaded coating, and a drug-loaded film is attached to the inner surface of the nickel-titanium stent. The body of the prepared multifunctional anti-stenosis drug-coated stent is a nickel-titanium stent and has good biocompatibility, the outer surface of the stent is coated with PLLA-TPU-based drug-loaded coating suspension slurry, the stent has good degradation performance and adjustable mechanical performance, inward or outward overgrowth of tumor cells can be effectively inhibited through drug release, and the anti-stenosis drug-coated stent has good anti-stenosis effect on tumor cells. Meanwhile, the medicine carrying membrane on the inner layer of the nickel-titanium stent can effectively inhibit tumor cells and effectively prevent bile mud from being deposited, and the nickel-titanium stent can be used for treating biliary tract stenosis diseases. The invention further provides a preparation method of the multifunctional anti-stenosis drug coating stent, the stent is prepared through a liquid flame spraying technology and a lamination method, the preparation method is simple, and the preparation period is short.
Owner:NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI +3

Medical double-core-layer pressure-resistant sensing balloon and preparation method thereof

The invention discloses a medical double-core-layer pressure-resistant sensing balloon and a preparation method thereof.The medical double-core-layer pressure-resistant sensing balloon comprises a balloon body connected with a catheter, the balloon body is of a double-core-layer shell layer structure, and a core layer comprises a developing and pressure sensing double-core structure; a developing agent is loaded in the inner core layer balloon, the position of the balloon is effectively displayed, it can be guaranteed that the core layer is not affected after the outer layer is damaged, the inner layer and the other core layer balloon can synchronously conduct pressure sensing, and the shell layer is a compression layer with toughness and bursting pressure and can be coated with a medicine coating. According to the medical double-core-layer high-pressure-resistant balloon provided by the invention, through the design of the internal double core layers, accurate control of pressure is effectively realized, and the problem that a developing agent leaks out of the brain after the outer layer of the balloon is broken in a trigeminal nerve minimally invasive puncture balloon compression operation is prevented; and by controlling the surface roughness of the outer layer, medicine coating can be carried out, so that vagus nerve reflex is prevented, and the problem of high risks of sudden blood pressure rise and sudden heartbeat arrest caused by compression in the operation process is solved.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1

A pharmaceutical coating condition detection system and method

This invention relates to the field of tablet preparation technology, specifically to a drug coating state detection system and method. The system includes a surface pretreatment module, a coating execution module, an online monitoring module, a data processing module, and a control module. The pretreatment module removes contaminants and enhances activity through plasma treatment, thereby improving coating adhesion. The coating execution module uses a fluidized bed environment, combined with a multi-channel spray gun and attitude control, to achieve uniform coating. The online monitoring module simultaneously acquires three-dimensional morphology, spectral, and image data, suppressing interference to ensure reliability. The data processing module calculates thickness and uniformity indicators, using machine learning to correlate process and quality. The control module dynamically adjusts parameters based on quality parameters using a PID algorithm, initiating emergency handling in case of anomalies. The method corresponds to the above steps. This invention improves coating adhesion and uniformity, achieves real-time monitoring and precise control, reduces the difficulty and cost of quality control, and is applicable to the production of various functional tablet coatings.
Owner:HEBEI LONG LIVE PHARM CO LTD

Pressure regulation system and method of regulating fluid pressure in lumen of medical device

PendingCN121371444ABalloon catheterBlood vessel remodelingBlood vessel
The invention provides a pressure adjusting system and a method for adjusting the pressure of fluid in an inner cavity of medical equipment, and relates to a method for controlling a pressure control pump to enable the pressure of the fluid in the inner cavity of the medical equipment to change within a period of time. A coronary artery blood vessel remodeling catheter, a peripheral balloon dilatation catheter, a peripheral blood vessel remodeling catheter, an intracranial laser balloon dilatation catheter, a drug coating balloon dilatation catheter, a photodynamic balloon catheter, a mastoid balloon catheter, a constraint type balloon dilatation catheter and a spinous process balloon can be made. Expansion and contraction of a balloon body in a balloon catheter such as a drug delivery balloon catheter are regularly changed within a period of time, and therefore the treatment effect is better achieved.
Owner:HANGZHOU LITTLE LIME MEDICAL TECH CO LTD